College of Pharmacy, Chung-Ang University, Dongjak-gu, Seoul 06974, Korea.
Department of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi-do 14662, Korea.
Int J Nanomedicine. 2019 May 17;14:3629-3644. doi: 10.2147/IJN.S191126. eCollection 2019.
A very common and simple method (known as the blending method) to formulate drug delivery systems with required properties is to physically mix amphiphilic block copolymers with different hydrophobicity. In addition to its simplicity, this blending strategy could help avoid the time and effort involved in the synthesis of block copolymers with the desired structure required for specific drug formulations. We used the blending strategy to design a system that could overcome the problem of high hydrophobicity and be a good candidate for drug product development using PEG-PLA-PEG triblock copolymers. Two types of PEG-PLA-PEG triblock copolymers with similar (long) PLA molecular weights (MWs) and different PEG MWs were synthesized. The micellar formulations were prepared by blending the two block copolymers in various ratios. The size and stability of the blending systems were subsequently investigated to optimize the formulations for further studies. The loading properties of doxorubicin or paclitaxel into the optimized blending system were compared to that in mono systems (systems composed of only a single type of triblock copolymer). In vitro and in vivo anti-cancer effects of the preparations were evaluated to assess the use of the blending system as an optimal nanomedicine platform for insoluble anticancer agents. The blending system (B20 system) with an optimized ratio of the triblock copolymers overcame the drawbacks of mono systems. Drug uptake from the drug-loaded B20 system and its anticancer effects against KB cells were superior compared to those of free drugs (doxorubicin hydrochloride and free paclitaxel). In particular, doxorubicin-loaded B20 resulted in extensive doxorubicin accumulation in tumor tissues and significantly higher in vivo anti-cancer effects compared to free doxorubicin. The blending system reported here could be a potential nanoplatform for drug delivery due to its simplicity and efficiency for pharmaceutical application.
用物理混合具有不同疏水性的两亲性嵌段共聚物来制备具有所需性质的药物传递系统是一种非常常见且简单的方法(称为共混法)。除了简单之外,这种共混策略还可以帮助避免合成具有特定药物制剂所需结构的嵌段共聚物所需的时间和精力。我们使用共混策略设计了一种系统,该系统可以克服疏水性高的问题,并成为使用 PEG-PLA-PEG 三嵌段共聚物进行药物产品开发的良好候选物。我们合成了两种具有相似(长)PLA 分子量(MW)和不同 PEG MW 的 PEG-PLA-PEG 三嵌段共聚物。通过以不同比例混合两种嵌段共聚物来制备胶束制剂。随后研究了共混体系的尺寸和稳定性,以优化制剂,进一步研究。比较了载药胶束制剂中阿霉素或紫杉醇的载药量与单体系(仅由单一类型嵌段共聚物组成的体系)的载药量。评估了制剂的体外和体内抗癌效果,以评估共混体系作为不溶性抗癌药物的最佳纳米医学平台的用途。具有嵌段共聚物优化比例的共混体系(B20 体系)克服了单体系的缺点。与游离药物(盐酸阿霉素和游离紫杉醇)相比,从载药 B20 系统摄取药物及其对 KB 细胞的抗癌作用都更好。特别是,与游离阿霉素相比,载药 B20 导致阿霉素在肿瘤组织中的大量积累,并具有更高的体内抗癌效果。由于其简单性和在药物应用方面的高效性,所报道的共混系统可能成为药物传递的潜在纳米平台。